Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00177788 · ClinicalTrials.gov registry record
Voriconazole as Prophylaxis for Liver Transplant Recipients
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 800
- Enrollment target
NCT00177788 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 800 participants.
The verdict
NCT00177788 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 800 participants
- Enrollment target
Study Summary
The study aims to determine if voriconazole prevents invasive fungal infections in liver transplant recipients. Endpoints would be: occurrence of invasive fungal infection and fungal colonization. Two groups will be compared: patients who received voriconazole as prophylaxis and historical controls who did not receive this prophylaxis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2005-09 |
| Est. Completion | 2012-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00177788
The ClinicalTrials.gov registry entry for NCT00177788 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00177788 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00177788 about?
NCT00177788 is a clinical study titled "Voriconazole as Prophylaxis for Liver Transplant Recipients". The study aims to determine if voriconazole prevents invasive fungal infections in liver transplant recipients. Endpoints would be: occurrence of invasive fungal infection and fungal colonization. Two groups will be compared: patients who received voriconazole as prophylaxis and historical controls ...
What is the current status of trial NCT00177788?
This trial is currently completed. The enrollment target is 800 participants. The study started on 2005-09. Estimated completion is 2012-08.
Who is sponsoring clinical trial NCT00177788?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.